Post-approval studies (Phase 4)Study completedNCT00331162
What this trial is testing
Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation
Who this might be right for
Graft Rejection
Wake Forest University Health Sciences 222